Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference31 articles.
1. Modern management of portal hypertension.;Lubel;Intern Med J,2005
2. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.;Lubel;J Gastroenterol Hepatol,2008
3. Cellular and molecular basis of portal hypertension.;Shah;Clin Liver Dis,2001
4. Biology of portal hypertension.;McConnell;Hepatol Int,2018
5. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.;Lee;Gastroenterology,1993
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association of Dipeptidyl Peptidase-4 Inhibitors Use with Reduced Risk of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Chronic HBV Infection;Cancers;2023-02-10
2. To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases;Journal of the Chinese Medical Association;2022-10-24
3. Outstanding research paper awards of the Journal of the Chinese Medical Association in 2021;Journal of the Chinese Medical Association;2022-09
4. Sodium-Glucose Cotransporter-2 Inhibition Exacerbates Hepatic Encephalopathy in Biliary Cirrhotic Rats;Journal of Pharmacology and Experimental Therapeutics;2022-08-04
5. Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats;International Journal of Molecular Sciences;2022-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3